510(k) · Cleared
ClearedBioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology; BioFlo PICC with ENDEXO Technology and PASV Valve Technology; BioFlo PICC with ENDEXO Technology; BioFlo Midline Catheter; Xcela Power Injectable PICC; Xcela PICC with PASV Valve Technology; Xcela Hybrid PICC with PASV Valve Technology
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Spectrum Vascular · LJS Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days
Cleared on Dec 16, 2025 as substantially equivalent to K163452 (Navilyst Medical, Inc., 2017) after a 139-day review. Its family tree reaches back 14 generations to 2000. 2 of the 48 devices in its family, counting itself, have a Class I recall.
- Decided
- Dec 16, 2025
- Review
- 139 days
- Class
- Class II
- Product code
- LJS
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 14 generations to K001901 (2000). 47 ancestors in all, the oldest K830256 (1983). No later device cites it as a predicate yet. 2 of the 48 devices in this family, counting this one, have a Class I recall.
- Root · 14 generations backK001901 Poly Per-Q-Cath Picc Catheter,Model 3236100 and Poly Per-Q-Cath…C.R. Bard, Inc. · 2000 · Recalled
- 10 generations between
- 3 generations backK131038 Nmi Picc Maximal Barrier Nursing KitsNavilyst Medical, Inc. · 2013 · Recalled
- 2 generations backK142616 PICC Maximal Barrier Nursing KitNavilyst Medical, Inc. · 2014 · Recalled
- 1 generation backK163452 PICC Maximal Barrier Nursing KitNavilyst Medical, Inc. · 2017 · Recalled
- This deviceK252373 BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology…Spectrum Vascular · 2025
Show all 14 generations
- Root · 14 generations backK001901 Poly Per-Q-Cath Picc Catheter,Model 3236100 and Poly Per-Q-Cath…C.R. Bard, Inc. · 2000 · Recalled
- 13 generations backK012902 Poly Per-Q-Cath Single Lumen Picc Catheter, Model 3143100; Poly…C.R. Bard, Inc. · 2001
- 12 generations backK031129 Poly Per-Q-Cath Picc Catheters; Poly RadpiccC.R. Bard, Inc. · 2003
- 11 generations backK033389 Powerpicc Catheters, Models 3175155, 3175135C.R. Bard, Inc. · 2004 · Recalled
- 10 generations backK050185 Powerhohn and Powerline CathetersC.R. Bard, Inc. · 2005
- 9 generations backK051417 6 FR FL Powerhohn and Powerline CatheterC.R. Bard, Inc. · 2005 · Recalled
- 8 generations backK051991 Powerpicc, Poly Per-Q-Cath, 6 FR TL Poly Per-Q-Cath, Power Hohn and…C.R. Bard, Inc. · 2005
- 7 generations backK061179 Powerhickman Long-Term Intravascular CatheterC.R. Bard, Inc. · 2006
- 6 generations backK101326 NMI ICNavilyst Medical, Inc. · 2010
- 5 generations backK111906 Xcela Hybrid Picc with Pasv Valve TechnologyNavilyst Medical, Inc. · 2011
- 4 generations backK122882 Nmi Hpicc IiiNavilyst Medical, Inc. · 2012
- 3 generations backK131038 Nmi Picc Maximal Barrier Nursing KitsNavilyst Medical, Inc. · 2013 · Recalled
- 2 generations backK142616 PICC Maximal Barrier Nursing KitNavilyst Medical, Inc. · 2014 · Recalled
- 1 generation backK163452 PICC Maximal Barrier Nursing KitNavilyst Medical, Inc. · 2017 · Recalled
- This deviceK252373 BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology…Spectrum Vascular · 2025
Class I recalls in this family
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −14 | K001901 | Poly Per-Q-Cath Picc Catheter,Model 3236100 and Poly Per-Q-Cath Midline… | C.R. Bard, Inc. | 2000 | 2 |
| −13 | K012902 | Poly Per-Q-Cath Single Lumen Picc Catheter, Model 3143100; Poly Per-Q-Cath… | C.R. Bard, Inc. | 2001 | — |
| −12 | K031129 | Poly Per-Q-Cath Picc Catheters; Poly Radpicc | C.R. Bard, Inc. | 2003 | — |
| −11 | K033389 | Powerpicc Catheters, Models 3175155, 3175135 | C.R. Bard, Inc. | 2004 | 1 |
| −10 | K050185 | Powerhohn and Powerline Catheters | C.R. Bard, Inc. | 2005 | — |
| −9 | K051417 | 6 FR FL Powerhohn and Powerline Catheter | C.R. Bard, Inc. | 2005 | 1 |
| −8 | K051991 | Powerpicc, Poly Per-Q-Cath, 6 FR TL Poly Per-Q-Cath, Power Hohn and Power Line | C.R. Bard, Inc. | 2005 | — |
| −7 | K061179 | Powerhickman Long-Term Intravascular Catheter | C.R. Bard, Inc. | 2006 | — |
| −6 | K101326 | NMI IC | Navilyst Medical, Inc. | 2010 | — |
| −5 | K111906 | Xcela Hybrid Picc with Pasv Valve Technology | Navilyst Medical, Inc. | 2011 | — |
| −4 | K122882 | Nmi Hpicc Iii | Navilyst Medical, Inc. | 2012 | — |
| −3 | K131038 | Nmi Picc Maximal Barrier Nursing Kits | Navilyst Medical, Inc. | 2013 | 12 |
| −2 | K142616 | PICC Maximal Barrier Nursing Kit | Navilyst Medical, Inc. | 2014 | 13 |
| −1 | K163452 | PICC Maximal Barrier Nursing Kit | Navilyst Medical, Inc. | 2017 | 5 |
| 0 (this device) | K252373 | BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology; BioFlo… | Spectrum Vascular | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1983 | 1 | 0 |
| 1986 | 1 | 1 |
| 1991 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 1 |
| 2001 | 4 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2004 | 4 | 0 |
| 2005 | 3 | 0 |
| 2006 | 3 | 0 |
| 2007 | 2 | 0 |
| 2008 | 1 | 0 |
| 2009 | 3 | 0 |
| 2012 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LJS device
- #1 K241910 Neonav ECG Tip Location Systemscore 18.0 · 12 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K163452 | PICC Maximal Barrier Nursing KitSummary page 7…PICC Maximal Barrier Nursing Kits Common Name: Peripherally Inserted Central Catheter (PICC) 510(k) Number: K163452 Manufacturer: Navilyst Medical, Inc. The predicate device has not been subject to… | 2017 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (2 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K993691Arrowg +Ard Blue Plus Antimicrobial Multi-Lumen Central Venous CatheterArrow Intl., Inc. · 2000 · 8 generations back · ◆ in the 2000 ancestors bar of FIG. 11 Class I recall
- K862056[Central Venous][Multi-Lumen] Catheter W/Flex TipArrow Intl., Inc. · 1986 · 9 generations back · ◆ in the 1986 ancestors bar of FIG. 11 Class I recall
What does this lineage say?
- The line of descent spans 25 years and passes through 3 companies; a new generation was cleared every 1.2 years on median.
- 18 of the 47 ancestors have a recall of any class; 2 have a Class I recall.
How does its category compare?
All LJS devicesLJS Catheter, Intravascular, Therapeutic, Long-Term Greater Than 30 Days: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.
FDA decisions per year · LJS
8in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LJS
171in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LJS
5in 2023
Class I (3 since 2007) Class II/III not classified
Adverse event reports per year · LJS
4,372in 2025
MAUDE reports naming product code LJS, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 14 | 92 | 0 | 392 |
| 2008 | 4 | 97 | 1 | 369 |
| 2009 | 16 | 70 | 1 | 379 |
| 2010 | 9 | 114 | 12 | 495 |
| 2011 | 6 | 55 | 4 | 696 |
| 2012 | 14 | 77 | 40 | 564 |
| 2013 | 14 | 31 | 0 | 680 |
| 2014 | 8 | 47 | 15 | 842 |
| 2015 | 7 | 71 | 2 | 1,306 |
| 2016 | 9 | 128 | 18 | 1,123 |
| 2017 | 7 | 101 | 9 | 2,100 |
| 2018 | 10 | 148 | 3 | 2,324 |
| 2019 | 0 | — | 0 | 2,052 |
| 2020 | 2 | — | 0 | 2,539 |
| 2021 | 3 | 284 | 1 | 3,084 |
| 2022 | 3 | 177 | 0 | 3,256 |
| 2023 | 4 | 47 | 5 (2) | 2,799 |
| 2024 | 1 | — | 0 | 4,243 |
| 2025 | 8 | 171 | 0 | 4,372 |
| 2026 | 2 | — | 8 (1) | — |
What is it indicated for?
BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology The BioFlo Hybrid PICC with ENDEXO and PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. Non-valved lumens are indicated for central venous pressure…
Read the full statement (660 words)
BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology
The BioFlo Hybrid PICC with ENDEXO and PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. Non-valved lumens are indicated for central venous pressure monitoring. 6F catheter is indicated for patients weighing >10 kg.
Maximum Power Injection Flow Rate:
• 6F Triple Lumen / 55 cm - 6 mL/sec
BioFlo PICC with ENDEXO and PASV Valve Technology
The BioFlo PICC with ENDEXO and PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. 6F catheter is indicated for patients weighing >10 kg.
Maximum Power Injection Flow Rate:
• 3F Single Lumen/55 cm - 1 mL/sec
• 4F Single Lumen/55 cm - 3.5 mL/sec
• 5F Single Lumen/55 cm - 5 mL/sec
• 5F Dual Lumen/55 cm - 4 mL/sec
• 6F Dual Lumen/55 cm - 5 mL/sec
• 6F Triple Lumen/55 cm - 6 mL/sec
BioFlo PICC with ENDEXO Technology
The BioFlo PICC with ENDEXO Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications, nutrients; the sampling of blood; for central venous pressure monitoring and for power injection of contrast media. 6F catheter is indicated for patients weighing >10 kg.
Maximum Power Injection Flow Rate:
• 3F Single Lumen/55 cm - 1 mL/sec
• 4F Single Lumen/55 cm - 3.5 mL/sec
• 5F Single Lumen/55 cm - 5 mL/sec
• 5F Dual Lumen/55 cm - 4 mL/sec
• 6F Dual Lumen/55 cm - 5 mL/sec
• 6F Triple Lumen/55 cm - 6 mL/sec
BioFlo Midline Catheter
The BioFlo Midline Catheter is indicated for short term access (< 30 days) to the peripheral venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and the sampling of blood and blood products.
Maximum Power Injection Flow Rate:
• 3F Single Lumen/20 cm - 2 mL/sec
• 4F Single Lumen/20 cm - 6 mL/sec
• 5F Single Lumen/20 cm - 6 mL/sec
• 5F Dual Lumen/20 cm - 6 mL/sec
Xcela Power Injectable PICC
The Xcela Power Injectable PICC is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. 6F catheter is indicated for patients weighing >10 kg.
Maximum Power Injection Flow Rate:
• 4F Single Lumen/45 cm - 4 mL/sec
• 4F Single Lumen/55 cm - 3.5 mL/sec
• 5F Single Lumen/55 cm - 5 mL/sec
• 5F Dual Lumen/45 cm - 5 mL/sec
• 5F Dual Lumen/55 cm - 4 mL/sec
• 6F Dual Lumen/55 cm - 5 mL/sec
Xcela PICC with PASV Valve Technology
The Xcela PICC with PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. 6F catheter is indicated for patients weighing >10 kg.
Xcela Hybrid PICC with PASV Technology
The Xcela Hybrid PICC with PASV Valve Technology is indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. Non-valved lumens are indicated for central venous pressure monitoring. 6F catheter is indicated for patients weighing >10 kg.
Maximum Power Injection Flow Rate:
• 6F Triple Lumen/55 cm - 6 mL/sec
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K252373 · printed Nov 4, 2026
Cite this page
510(k) Report. “K252373: BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology; BioFlo PICC with ENDEXO Technology and PASV Valve Technology; BioFlo PICC with ENDEXO Technology; BioFlo Midline Catheter; Xcela Power Injectable PICC; Xcela PICC with PASV Valve Technology; Xcela Hybrid PICC with PASV Valve Technology.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K252373
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026